Evidence-based guideline for dust mite allergen immunotherapy in children with allergic asthma (Patient Version)
10.3760/cma.j.cn101070-20240417-00239
- VernacularTitle:儿童过敏性哮喘尘螨过敏原特异性免疫治疗循证指南(患者版)
- Keywords:
Child;
Allergic asthma;
Dust mite;
Allergen immunotherapy
- From:
Chinese Journal of Applied Clinical Pediatrics
2024;39(6):418-425
- CountryChina
- Language:Chinese
-
Abstract:
The prevalence of allergic asthma(AA) in children is increasing trend.Dust mite is the most common inhaled allergen.Dust mite allergen immunotherapy(AIT)is the cause treatment of allergic diseases.However, the public′s understanding of AIT is insufficient and there is a lack of specific guideline of dust mite AIT for children with AA and their parents.Therefore, based on evidence-based medicine at home and abroad, combined with the experience of experts and the needs of children and parents, this guideline was formulated, which includes suitable crowd, treatment time, treatment approaches, curative effect judgment, adverse reactions and drug combination of dust mite AIT.This guideline aims to improve the awareness and compliance of dust mite AIT in children with AA and their parents, and achieve comprehensive management of AA in children with a " four in one" manner.
